📊 SCORAD Atopic Dermatitis Composite Index Simulator

Extent (A) — Mapping Affected Body Surface Area

Placeholder: extent uses a rule-of-nines body map scored zero to one hundred.

• 0–100: Score range (percent body surface)
• Rule of nines: Method (placeholder text)
• A/5: Weight in formula (placeholder text)
• Clinician: Assessor (placeholder text)

How extent is measured

Placeholder: clinician estimates percent skin surface affected by eczema.

Intensity (B) — Six Clinical Signs Scored

Placeholder: six signs each scored zero to three for a max of eighteen.

• 6: Signs scored (placeholder text)
• 0–3: Each sign range (placeholder text)
• 18: Max total B (placeholder text)
• 7B/2: Weight in formula (placeholder text)

The six signs

Placeholder: erythema, edema, oozing, excoriation, lichenification, dryness.

Subjective (C) — Itch and Sleep Loss

Placeholder: patient rates itch and sleep loss on ten-point scales.

• 0–10: Itch scale (placeholder text)
• 0–10: Sleep loss scale (placeholder text)
• 20: Max total C (placeholder text)
• Patient: Reporter (placeholder text)

Why subjective symptoms matter

Placeholder: captures quality-of-life burden objective signs miss.

Combining A, B, and C into One Score

Placeholder: SCORAD = A/5 + 7B/2 + C weights each component.

• A/5+7B/2+C: Formula (placeholder text)
• 83: Objective max (placeholder text)
• 20: Subjective max (placeholder text)
• 103: Total max (placeholder text)

Why these weights

Placeholder: weighting reflects each component's clinical importance.

Total SCORAD — Classifying Disease Severity

Placeholder: total score sorts patients into mild, moderate, severe bands.

• <25: Mild (placeholder text)
• 25–50: Moderate (placeholder text)
• >50: Severe (placeholder text)
• 103: Max possible (placeholder text)

Using the score clinically

Placeholder: guides treatment intensity and tracks response over time.

Placeholder: SCORAD is widely used in eczema trials and clinics.